SCHEMBL1665028

SCHEMBL1665028

CC[C](O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL269749 0.74
SCHEMBL6860790 0.72
SCHEMBL3031143 0.72
SCHEMBL3668338 0.72
SCHEMBL4581077 0.69
SCHEMBL6438316 0.69
SCHEMBL270838 0.69
SCHEMBL7357059 0.67
SCHEMBL20212143 0.67
Propionic Acid SCHEMBL11428745 0.65 FFAR3 (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2872502-B1 NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION HOFFMANN LA ROCHE (CH) 2016-08-24 EP claimed
US-20160200741-A1 Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection HOFFMANN-LA ROCHE INC. (US) 2016-07-14 US claimed
US-9206191-B2 Indazoles for the treatment and prophylaxis of respiratory syncytial virus infection HOFFMANN-LA ROCHE INC. (US) 2015-12-08 US claimed
US-20150158879-A1 Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection HOFFMANN-LA ROCHE INC. (US) 2015-06-11 US claimed
EP-2872502-A1 NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2015-05-20 EP claimed
WO-2014009302-A1 NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2014-01-16 WO claimed
EP-2317982-B1 METHODS OF PROCESSING COMPOSITIONS CONTAINING MICROPARTICLES BAXTER INT (US) 2017-10-11 EP disclosed
EP-2872502-B1 NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION HOFFMANN LA ROCHE (CH) 2016-08-24 EP disclosed
US-20160200741-A1 Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection HOFFMANN-LA ROCHE INC. (US) 2016-07-14 US disclosed
US-9206191-B2 Indazoles for the treatment and prophylaxis of respiratory syncytial virus infection HOFFMANN-LA ROCHE INC. (US) 2015-12-08 US disclosed
EP-2334393-B1 METHODS OF PROCESSING MULTI-PHASIC DISPERSIONS BAXTER INT (US) 2015-12-02 EP disclosed
US-20150158879-A1 Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection HOFFMANN-LA ROCHE INC. (US) 2015-06-11 US disclosed
EP-2872502-A1 NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2015-05-20 EP disclosed
WO-2010022276-A2 METHODS OF PROCESSING MULTI-PHASIC DISPERSIONS BAXTER INTERNATIONAL INC. (US) 2010-02-25 WO disclosed
WO-2010022282-A1 METHODS OF PROCESSING MICROPARTICLES BAXTER INTERNATIONAL INC. (US) 2010-02-25 WO disclosed
EP-0758352-B2 AQUEOUS SUSPENSION OF A CELLULOSE ETHER, METHOD FOR THE PRODUCTION THEREOF, AND COMPOSITION BEROL NOBEL AB (SE) 2002-09-18 EP disclosed
US-5898072-A CROSSLINKED WITH GLYOXAL, ELECTROLYTIC SALT WHICH GIVES A PH VALUE BELOW 8.0 IN WATER AKZO NOBEL NV (NL) 1999-04-27 US disclosed
EP-0758352-B1 AQUEOUS SUSPENSION OF A CELLULOSE ETHER, METHOD FOR THE PRODUCTION THEREOF, AND COMPOSITION BEROL NOBEL AB (SE) 1999-04-07 EP disclosed
EP-0758352-A1 AQUEOUS SUSPENSION OF A CELLULOSE ETHER, METHOD FOR THE PRODUCTION THEREOF, AND COMPOSITION BEROL NOBEL AB (SE) 1997-02-19 EP disclosed
WO-1995030705-A1 AQUEOUS SUSPENSION OF A CELLULOSE ETHER, METHOD FOR THE PRODUCTION THEREOF, AND COMPOSITION BEROL NOBEL AB (SE) 1995-11-16 WO disclosed